Related Experiment Videos

Effect of the platelet-derived growth factor antagonist trapidil on mesangial cell proliferation in rats

A Futamura1, K Izumino, Y Nakagawa

  • 12nd Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Nephron
|March 30, 1999
PubMed

Insights

Trapidil, a platelet-derived growth factor (PDGF) antagonist, effectively reduced mesangial cell proliferation in cell cultures and in a rat model of nephritis. This suggests trapidil

Area of Science:

  • Nephrology
  • Cell Biology
  • Pharmacology

Background:

  • Platelet-derived growth factor (PDGF) is a key mediator of mesangial cell proliferation.
  • Mesangial cell proliferation is implicated in mesangial proliferative nephritis.

Purpose of the Study:

  • To investigate the effect of trapidil, a PDGF antagonist, on mesangial cell proliferation.
  • To evaluate trapidil's efficacy in an anti-Thy-1.1 nephritis rat model.

Main Methods:

  • Assessed 3H-thymidine incorporation in PDGF-stimulated mesangial cells in culture.
  • Administered trapidil to rats with anti-Thy-1.1 nephritis.
  • Quantified glomerular cell counts and proliferating cell nuclear antigen (PCNA) positive cells.

Main Results:

  • Trapidil dose-dependently inhibited PDGF-induced mesangial cell proliferation in vitro.
  • Trapidil treatment significantly reduced total and proliferating glomerular cells in anti-Thy-1.1 nephritis rats.
  • No significant differences in blood urea nitrogen or creatinine levels were observed between groups.

Conclusions:

  • Trapidil demonstrates a beneficial effect on mesangial cell proliferation.
  • PDGF plays a significant role in mediating mesangial cell proliferation in nephritis.
  • Trapidil warrants further investigation for potential therapeutic applications in kidney diseases involving mesangial cell proliferation.

Related Concept Videos